Industry News
Form of permanent radiotherapy may prolong prostate cancer suvival, study finds
4/27/2015
Compared with dose-escalated external beam radiotherapy, low-dose-rate prostate brachytherapy may prolong survival for patients with prostate cancer, a new study finds.
Study illuminates role of cancer drug decitabine in repairing damaged cells
4/27/2015
A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to...
New therapeutic target for a type of colorectal cancer with poor prognosis has been identified
4/26/2015
Researchers at the Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer.
Global Hepatitis B epidemic can be treated for $36 (£24) per person per year
4/26/2015
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus (HBV) could be mass-produced for only £24 ($36) per person per year, versus the current UK NHS...
Ovary removal linked with 62% reduction in BRCA1-related breast cancer deaths
4/25/2015
The benefits of oophorectomy, the procedure to remove the ovaries, are confirmed in a new study published in JAMA Oncology that examines survival among breast cancer patients.
Combined brachytherapy techniques should be "benchmark" for cervical cancer treatment
4/24/2015
The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers...
Amgen has announced the initiation of a clinical trial, NCT02366195, to determine whether baseline CD8+ T lymphocytes density is a biomarker of response to talimogene laherparepvec, an...
Despite the majority of newly diagnosed advanced non-small cell lung cancer (NSCLC) patients being tested for genetic mutations, a gap still exists for providing a personalized treatment plan for...
Transgene announces new pre-clinical data for two of its programs - TG4010 and TG3003
4/24/2015
Transgene SA has announced that new pre-clinical data for two of its programs - TG4010 and TG3003 - were presented at the Annual Meeting of the American Association for Cancer Research (AACR) in...
Genomic analyses point to the potential of personalised care for liver cancer patients
4/24/2015
A new study presented at The International Liver Congress 2015 shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma...